Sectoral Asset Management has held a final close for New Emerging Medical Opportunities (NEMO) Fund IV, securing US $96 million in aggregate capital commitments.
Limited partners of the fund include investors from North America, Switzerland, Italy, France, Austria, Hong Kong, and Singapore. They represent institutions, family offices, independent asset managers, and private banks.
Sectoral’s New Emerging Medical Opportunities (NEMO) strategy is focused on companies involved in the development of new pharmaceuticals, medical technology devices and related products to serve the global healthcare market.
Founded in 2000, Sectoral Asset Management Inc. is an industry-leading specialist in managing global investment portfolios in the healthcare sector. Sectoral’s first private equity investments were made by allocating assets to this class from its small-cap funds (NEMO I and NEMO II). Sectorial launched the first dedicated fund, NEMO III, in 2015.
NEMO private equity team is led by Senior Partner, Michael Sjöström, and Partners, Marc-André Marcotte and Stefan Larson.
NEMO IV has already made three investments and looks to complete over a dozen transactions across the medtech and biotech sectors.
photo credit: Sectoral Asset Management
Final Closing of New Emerging Medical Opportunities (NEMO) IV Fund
Montreal, May 22, 2020. Sectoral Asset Management is happy to announce the final closing of our New Emerging Medical Opportunities (NEMO) Fund IV at USD96mio.
We are very proud of this milestone, occurring as it does in these difficult times, and wish to thank all of our NEMO III limited partners, who have decided to invest in this fund as well. We also are grateful to the new LPs who have joined our venture. Our LPs are based in North America, Switzerland, Italy, France, Austria, Hong Kong, and Singapore. They represent institutions, family offices, independent asset managers, and private banks.
Between 2009 and December 2019, our NEMO program generated a net return of 2.5X (IRR +44%)*. Sectoral has built a team of eight investment professionals, primarily based in our Montreal office, to source candidates, perform due diligence, and execute deals. We look forward to deploying NEMO IV in the future and are convinced that the current dislocations will create interesting opportunities for astute investors. NEMO IV has already executed three deals, and we plan to use the Fund over a dozen transactions across the medtech and biotech sectors.
Sectoral Asset Management
For further information, please contact:
Michael Sjöström, CFA
Founded in 2000, Sectoral Asset Management is specialized in managing global investment portfolios of the healthcare sector and is in the sector one of the industry leading companies. Sectoral maintains offices in Montreal, Geneva and Hong Kong. The investment approach of the company is based on a primary analysis of company-specific fundamental healthcare data.